Table 1.

Primer and Oligonucleotide Sequences Used in the Present Research

A. Primers	Sequences (5ʹ-3ʹ)
CAR10 forward primer	TCTGCTGGACTTAGGCTGGT
CAR10 reverse primer	TGCTGCAGTGTGTGGCTATC
GJB2 forward primer	CCCGACGCAGAGCAAACC
GJB2 reverse primer	TAGCACACGTTCTTGCAGCC
GAPDH forward primer	CAAGGTCATCCATGACAACTTTG
GAPDH reverse primer	GTCCACCACCCTGTTGCTGTAG
miR-892a forward primer	GCGGCGGCACTGTGTCCTTTCTG
miR-892a reverse primer	ATCCAGTGCAGGGTCCGAGG
U6 forward primer	CTCGCTTCGGCAGCACA
U6 reverse primer	AACGCTTCACGAATTTGCGT
B. Oligonucleotide	Sequences (5ʹ-3ʹ)
siCAR10-1 forward	GAGUGACUCAUUCUCCUGUTT
siCAR10-1 reverse	ACAGGAGAAUGAGUCACUCTT
siCAR10-2 forward	CAGGUCAAAUCAGGAGGCUTT
siCAR10-2 reverse	AGCCUCCUGAUUUGACCUGTT
siCAR10-3 forward	AAUGUGACUAGACACAAAG
siCAR10-3 reverse	CUUUGUGUCUAGUCACAUU
siGJB2-1 forward	CAUUUAAAACAUUAAAAUA
siGJB2-1 reverse	UAUUUUAAUGUUUUAAAUG
siGJB2-2 forward	GCCUCAUGUCAAAUAUUUA
siGJB2-2 reverse	UAAAUAUUUGACAUGAGGC
siGJB2-3 forward	AGCAUUUUGUAAUAAUAAA
siGJB2-3 reverse	UUUAUUAUUACAAAAUGCU
oeCAR10 forward	GGTACCAGACACAAAGTAGCCCAGAG
oeCAR10 reverse	GAATTCAGCAGTTTGTGTTTACCTGTC
oeGJB2 forward	GGTACCCCCAGGACCCGCCTA
oeGJB2 reverse	GAATCCCATGTCAAGCATAATGGCAA
miR-892a mimic	CACUGUGUCCUUUCUGCGUAG
miR-892a inhibitor	CUACGCAGAAAGGACACAGUG